Kamada, Ltd.
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 (NCT04550325) | Kamada, Ltd. | 2020-08-05 |
| Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation" (NCT04204252) | Kamada, Ltd. | 2019-11-25 |
Track Kamada, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.